Brawn Biotech

Brawn Biotech Debt/EBITDA

Total Debt to EBITDA Ratio of Brawn Biotech (530207.BO) as of Oct 11, 2026.

Debt/EBITDA

0.00

Last updated:

Total Debt to EBITDA Ratio of Brawn Biotech is 2025 0.00 . Total Debt to EBITDA Ratio of Brawn Biotech was 2024 0.00 . It decreases by % lower compared to the previous year.

The Brawn Biotech Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2023
0.00 INR
Jan 1, 2024
0.00 INR
Jan 1, 2025
0.00 INR
The Brawn Biotech Debt/EBITDA history
YEARDebt/EBITDAYoY
0.00—
0.00—
0.00—
Access this data via the Eulerpool API
Get Free API Key

Brawn Biotech Stock analysis

What does Brawn Biotech do? Brawn Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Brawn Biotech stock

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Brawn Biotech since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Brawn Biotech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Leverage — Brawn Biotech

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Brawn Biotech